Rosa Señarís

Rosa Señarís

Auto-generated profile, based on publicly available information

Rosa Señarís

Department of Physiology Faculty of Medicine University of Santiago de Compostela Santiago de Compostela Spain

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2014 in Nature Communications
Verified
Journal Article
Open access
VMVictor Meseguer
Victor Meseguer
YAYeranddy A. Alpizar
Yeranddy A. Alpizar
ELEnoch Luis
Enoch Luis
STSendoa Tajada
Sendoa Tajada
BDBristol Denlinger
Bristol Denlinger
FVFelix Viana
Felix Viana
Gram-negative bacterial infections are accompanied by inflammation and somatic or visceral pain. These symptoms are generally attributed to sensitization of nociceptors by inflammatory mediators released by immune cells. Nociceptor sensitization during inflammation occurs through activation of the Toll-like receptor 4 (TLR4) signalling pathway by lipopolysaccharide (LPS), a toxic by-product of bacterial lysis. Here we show that LPS exerts fast, membrane delimited, excitatory actions via TRPA1, a transient receptor potential cation channel that is critical for transducing environmental irritant stimuli into nociceptor activity. Moreover, we find that pain and acute vascular reactions, including neurogenic inflammation (CGRP release) caused by LPS are primarily dependent on TRPA1 channel activation in nociceptive sensory neurons, and develop independently of TLR4 activation. The identification of TRPA1 as a molecular determinant of direct LPS effects on nociceptors offers new insights into the pathogenesis of pain and neurovascular responses during bacterial infections and opens novel avenues for their treatment.

1 February 2003 in Endocrinology
Verified
Journal Article
Open access
PDF file
LSLuisa M. Seoane
Luisa M. Seoane
Miguel LopezMiguel Lopez
Miguel Lopez
STSulay Tovar
Sulay Tovar
FCFelipe F Casanueva
Felipe F Casanueva
RSRosa SeñaRís
Rosa SeñaRís
CDCarlos DiégUez
Carlos DiégUez
Ghrelin, the endogenous ligand of the GH secretagogue receptor, acts at central level to elicit GH release and regulate food intake. To elucidate the neural circuit that exerts its effects, we measured the expression of hypothalamic neuropeptides involved in weight regulation and GH secretion after ghrelin administration. Adult male rats, fed or fasted for 72 h, were treated centrally (intracerebroventicularly) with a single dose of ghrelin (5 μg). After 2, 4, and 6 or 8 h, agouti-related peptide, melanin-concentrating hormone, neuropeptide Y, prepro-orexin, GHRH, and somatostatin mRNA levels were measured by in situ hybridization. We found that ghrelin increased agouti-related peptide and neuropeptide Y expression in the arcuate nucleus of the hypothalamus of fed and fasted rats. In contrast, no change was demonstrated in the mRNA levels of the other neuropeptides studied at any time evaluated. Finally, we examined the effect of ghrelin on GHRH and somatostatin mRNA levels in GH-deficient (dwarf) rats. Our results show that ghrelin increases somatostatin mRNA levels in the hypothalamus of these rats. This study furthers our understanding of the molecular basis and mechanisms involved in the effect of ghrelin on food intake and GH secretion.

1 March 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Miguel LopezMiguel Lopez
Miguel Lopez
LSLuisa Seoane
Luisa Seoane
MGMaría del Carmen García García
María del Carmen García García
FLFrancisca Lago
Francisca Lago
FCFelipe F Casanueva
Felipe F Casanueva
CDCarlos Diéguez
Carlos Diéguez

15 April 2013 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MRMarcos Ríos
Marcos Ríos
MFMarc Foretz
Marc Foretz
Benoit ViolletBenoit Viollet
Benoit Viollet
APAngel Prieto
Angel Prieto
MFMáximo Fraga
Máximo Fraga
RSRosa Señarís
Rosa Señarís
5′-AMP-activated protein kinase (AMPK) is an energy sensor that controls cell metabolism, and it has been related to apoptosis and cell-cycle arrest. Although its role in metabolic homeostasis is well documented, its function in cancer is much less clear. In this study, we examined the role of AMPK in a mouse model of astrocytoma driven by oncogenic H-RasV12 and/or with PTEN deletion based on the common constitutive activation of the Raf/MEK/ERK and PI3K/AKT cascades in human astrocytomas. We also evaluated the activity and role of AMPK in human glioblastoma cells and xenografts. AMPK was constitutively activated in astrocytes expressing oncogenic H-RasV12 in parallel with high cell division rates. Genetic deletion of AMPK or attenuation of its activity in these cells was sufficient to reduce cell proliferation. The levels of pAMK were always related to the levels of phosphorylated retinoblastoma (Rb) at Ser804, which may indicate an AMPK-mediated phosphorylation of Rb. We confirmed this AMPK–Rb relationship in human glioblastoma cell lines and xenografts. In clinical specimens of human glioblastoma, elevated levels of activated AMPK appeared especially in areas of high proliferation surrounding the blood vessels. Together, our findings indicate that the initiation and progression of astrocytic tumors relies upon AMPK-dependent control of the cell cycle, thereby identifying AMPK as a candidate therapeutic target in this setting. Cancer Res; 73(8); 2628–38. ©2013 AACR.

1 March 2000 in Biology of Reproduction
Verified
Journal Article
Closed access
MGMaría del Carmen García García
María del Carmen García García
FCFelipe F. Casanueva
Felipe F. Casanueva
CDCarlos Diéguez
Carlos Diéguez
RSRosa María Señarís
Rosa María Señarís
Serum leptin levels were significantly increased during rat gestation. Our data showed that leptin mRNA levels in both the adipose tissue and placenta were higher as pregnancy progressed, suggesting a role for both tissues in the hyperproduction of leptin. This paradoxical increase in leptin concentration during gestation suggests that a physiological state of leptin resistance may exist at the hypothalamic level that may explain the hyperphagia observed in pregnant rats. In order to study this issue further, levels of the mRNA encoding the different leptin receptor isoforms were determined in the hypothalamus of pregnant and nonpregnant rats. We found a specific reduction of the mRNA levels encoding the leptin receptor isoform Ob-Rb in the hypothalamus of pregnant rats compared to nonpregnant animals, suggesting that during pregnancy the hypothalamus shows a physiological resistance to the high levels of leptin due, at least in part, to a decrease in the expression of the long, biologically active form of the leptin receptor (Ob-Rb). During lactation, serum leptin levels returned to values observed in nonpregnant rats. In the hypothalami of these animals, Ob-Rb mRNA content was similar to that observed in nonpregnant rats, but we found an increased expression of some of the short forms of the leptin receptor (Ob-Re and Ob-Rf). This could contribute to induction of the hyperphagia present during lactation. These data provide new insights into the adaptive mechanisms that take place during pregnancy and lactation in order to meet increased metabolic requirements.

23 December 2004 in Diabetologia
Verified
Journal Article
Closed access
PDF file
LSL. M. Seoane
L. M. Seoane
STSulay Tovar
Sulay Tovar
RNRuben Nogueiras
Ruben Nogueiras
Miguel LopezMiguel Lopez
Miguel Lopez
MGMaría del Carmen García García
María del Carmen García García
RSR. M. Señarís
R. M. Señarís